Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study

This post hoc analysis assessed the effects on cardiovascular risk factors of body weight, systolic blood pressure (SBP) and triglycerides after 28 weeks’ treatment with exenatide once weekly plus dapagliflozin, as compared with exenatide once weekly or dapagliflozin, in patient subpopulations from...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbour, Serge A., Frías, Juan P., Guja, Cristian, Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969082/
https://www.ncbi.nlm.nih.gov/pubmed/29316164
http://dx.doi.org/10.1111/dom.13206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969082/
https://www.ncbi.nlm.nih.gov/pubmed/29316164
http://dx.doi.org/10.1111/dom.13206

Ejemplares similares